Retatrutide 30MG

Retatrutide is an investigational medication developed for the treatment of obesity and type 2 diabetes. It works as a triple agonist, targeting the GLP-1, GIP, and glucagon receptors to regulate appetite, improve glucose metabolism, and increase energy expenditure. By combining the effects of these pathways, Retatrutide has shown promising results in promoting significant weight loss and improving metabolic health in clinical trials.